Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Rapiscan“
Suchtreffer
Begriffe & Kennungen
Rapiscan
Eintrag öffnenRapiscan · 4.1 Therapeutic indications · 1
Eintrag öffnenRapiscan · 4.3 Contraindications · 1
Eintrag öffnenRapiscan · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Second or thir
Eintrag öffnenRapiscan · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenRapiscan · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenRapiscan · 4.5 · Cardioactive medicinal products In clinical studies, regadenoson was administered to patients taking other car
Eintrag öffnenRapiscan · 4.5 · Dipyridamole Dipyridamole increases blood adenosine levels and the response to regadenoson may be altered when
Eintrag öffnenRapiscan · 4.5 · Methylxanthines Methylxanthines (e.g., caffeine and theophylline) are non-specific adenosine receptor antagoni
Eintrag öffnenRapiscan · 4.5 · Other interactions Regadenoson does not inhibit the metabolism of substrates for CYP1A2, CYP2C8, CYP2C9, CYP2C
Eintrag öffnenRapiscan · 4.5 · Regadenoson does not significantly inhibit the transporters OAT1, OAT3, OCT1, OATP1B1, OATP1B3, MATE1, MATE2-K
Eintrag öffnenRapiscan · 4.5 · Regadenoson may have a modest inhibitory effect on the active renal transporter, OCT2, and has been found to b
Eintrag öffnenRapiscan · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenRapiscan · 4.8 Undesirable effects · 1
Eintrag öffnenRapiscan · 4.8 · 6 Nervous system disorders: Very common Headache, dizziness Common Paraesthesia, hypoaesthesia, dysgeusia Unco
Eintrag öffnenRapiscan · 4.8 · 7 decreased diastolic blood pressure (> 25 mm Hg) was observed in 4% of patients within 45 minutes of regadeno
Eintrag öffnenRapiscan · 4.8 · Description of selected adverse reactions Fatal cardiac arrest, life-threatening ventricular arrhythmias and m
Eintrag öffnenRapiscan · 4.8 · Elderly population Older patients (≥ 75 years of age; n = 321) had a similar adverse reaction profile compared
Eintrag öffnenRapiscan · 4.8 · Elevated blood pressure In clinical trials, increased systolic blood pressure (≥ 50 mm Hg) was observed in 0.7
Eintrag öffnenRapiscan · 4.8 · Headache Headache was reported by 27% of subjects who received regadenoson in clinical trials. The headache wa
Eintrag öffnen